Medicine

Irene Oi-lin Ng, G. Lyu

2026.4.1eGastroenterology

DOI: 10.1136/egastro-2026-100465

Abstract

The therapeutic landscape of advanced hepatocellular carcinoma (HCC) has undergone a paradigm shift with the advent of immune checkpoint blockade (ICB).

Citation format

NG, Irene Oi-lin; LYU, G. Immunotherapy in HCC: Aetiology matters. eGastroenterology, 2026, 4.